Caxton Associates LP

SEC CIK: 0000872573
Latest filing: Feb 14, 2025

SEC filings (opens in a new tab)

ENTA holding history

Enanta Pharmaceuticals Inc in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENTA overview All 13F holders of ENTA Full Q4 2024 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2022

Holdings of ENTA by Caxton Associates LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−18,028−100.0%	Sold out	Holders
Q3 2023	18,028	$201.4K	<0.1%	+18,028	New	Holders
Q3 2022	0	$0	0.0%	−13,843−100.0%	Sold out	Holders
Q2 2022	13,843	$654.0K	0.1%	+13,843	New	Holders